All News
Filter News
Found 4,653 articles
-
Avigen, Inc. To Present At CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference
3/29/2006
-
Wyeth Launches Unique Spanish-Language Patient Education And Support Program For EFFEXOR XR Depression Patients
3/27/2006
-
Avigen, Inc. Announces Management Changes; Chief Medical Officer Steps Down
3/26/2006
-
Baxter International, Inc. Announces Investment of $60 Million To Expand Manufacturing Capacity In China
3/23/2006
-
Baxter Healthcare Corporation Announces Launch Of Authorized Generic Azithromycin For Injection
3/23/2006
-
Avigen, Inc. Elects Richard Wallace To Board Of Directors
3/22/2006
-
Wyeth Pharmaceuticals (New Jersey) Announces Termination Of Phase 3 Clinical Program With Oral Temsirolimus In Women With Metastatic Breast Cancer
3/17/2006
-
Baxter International, Inc. First Quarter 2006 Financial Results Conference Call
3/16/2006
-
Grifols Acquires 15 Additional Plasma Collection Centers Through Acquisition Of PlasmaCare
3/14/2006
-
Abbott Laboratories Statement On Advancing Pediatric HIV Treatment In Developing Countries
3/13/2006
-
Baxter Healthcare Corporation Commences First-Of-Its-Kind, Phase II Adult Stem Cell Trial In U.S. in Patients With Severe Coronary Artery Disease
3/7/2006
-
Baxter Healthcare Corporation Study Verifies Inactivation Of Influenza H5N1 Virus During Manufacture Of Its Plasma-Derived Therapies
3/7/2006
-
Dendreon Corporation Names Ernest Bognar General Manager Of Hanover, NJ Manufacturing Facility
3/7/2006
-
ZLB Behring Release: Phase III Clinical Study Shows Vivaglobin(R), A New Subcutaneous Immunoglobulin, Is Safe And Effective In Treating Patients With Primary Immunodeficiency
3/6/2006
-
ZLB Behring Release: Study Shows Individual Replacement Therapy With C1-Inhibitor Concentrate Reduces Life-Threatening Hereditary Angioedema Attacks Compared With Current Treatment Of Choice
3/6/2006
-
ZLB Behring Release: Study Finds Treatment With C1-Inhibitor Concentrate Relieves Abdominal Pain In Hereditary Angioedema Patients
3/6/2006
-
Vesta Therapeutics, Inc. Announces Formation Of Scientific Advisory Board To Advance Development Of New Liver Therapies
3/6/2006
-
Wyeth Pharmaceuticals (New Jersey)' Antibiotic TYGACIL Receives 'Positive Opinion' From European Regulatory Authority
3/2/2006
-
Baxter International, Inc. And Its Foundation Contribute More Than $35 Million In 2005 To Communities In Need
3/2/2006
-
New Brunswick Scientific Expands Line Of BioFlo Pro Bioreactors With New Pilot- And Production-Scale Models
3/1/2006